Lineage Cell Therapeutics Inc (STU:BT3)
€ 0.855 0 (0%) Market Cap: 161.67 Mil Enterprise Value: 124.08 Mil PE Ratio: 0 PB Ratio: 2.39 GF Score: 73/100

Lineage Cell Therapeutics Inc (STU:BT3) Transcripts

  • 1